Dysregulation of the angiopoietin–Tie-2 axis in sepsis and ARDS

References

• Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 1983; 308:553 - 8; http://dx.doi.org/10.1056/NEJM198303103081002; PMID: 6402699
   PubMed Web of Science ®Google Scholar
• Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869 - 71; http://dx.doi.org/10.1126/science.3895437; PMID: 3895437
   PubMed Web of Science ®Google Scholar
• Tracey KJ, Lowry SF, Cerami A. Cachectin/TNF mediates the pathophysiological effects of bacterial endotoxin/lipopolysaccharide (LPS). Prog Clin Biol Res 1988; 272:77 - 88; PMID: 3293084
   PubMedGoogle Scholar
• Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662 - 4; http://dx.doi.org/10.1038/330662a0; PMID: 3317066
   PubMed Web of Science ®Google Scholar
• Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 1992; 148:2724 - 30; PMID: 1315357
   PubMed Web of Science ®Google Scholar
• Fisher CJ Jr., Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, et al, The Soluble TNF Receptor Sepsis Study Group. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 1996; 334:1697 - 702; http://dx.doi.org/10.1056/NEJM199606273342603; PMID: 8637514
   PubMed Web of Science ®Google Scholar
• Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, et al, ACCESS Study Group. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 2013; 309:1154 - 62; PMID: 23512062
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085 - 8; http://dx.doi.org/10.1126/science.282.5396.2085; PMID: 9851930
   PubMed Web of Science ®Google Scholar
• Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 1992; 7:1471 - 80; PMID: 1630810
   PubMed Web of Science ®Google Scholar
• Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A 1993; 90:9355 - 8; http://dx.doi.org/10.1073/pnas.90.20.9355; PMID: 8415706
   PubMed Web of Science ®Google Scholar
• Partanen J, Armstrong E, Mäkelä TP, Korhonen J, Sandberg M, Renkonen R, et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 1992; 12:1698 - 707; PMID: 1312667
   PubMed Web of Science ®Google Scholar
• Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994; 8:1897 - 909; http://dx.doi.org/10.1101/gad.8.16.1897; PMID: 7958865
   PubMed Web of Science ®Google Scholar
• Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55 - 60; http://dx.doi.org/10.1126/science.277.5322.55; PMID: 9204896
   PubMed Web of Science ®Google Scholar
• Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87:1171 - 80; http://dx.doi.org/10.1016/S0092-8674(00)81813-9; PMID: 8980224
   PubMed Web of Science ®Google Scholar
• Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103:4150 - 6; http://dx.doi.org/10.1182/blood-2003-10-3685; PMID: 14976056
   PubMed Web of Science ®Google Scholar
• Barton WA, Tzvetkova D, Nikolov DB. Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition. Structure 2005; 13:825 - 32; http://dx.doi.org/10.1016/j.str.2005.03.009; PMID: 15893672
   PubMed Web of Science ®Google Scholar
• Barton WA, Tzvetkova-Robev D, Miranda EP, Kolev MV, Rajashankar KR, Himanen JP, et al. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Nat Struct Mol Biol 2006; 13:524 - 32; http://dx.doi.org/10.1038/nsmb1101; PMID: 16732286
   PubMed Web of Science ®Google Scholar
• Kim KT, Choi HH, Steinmetz MO, Maco B, Kammerer RA, Ahn SY, et al. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J Biol Chem 2005; 280:20126 - 31; http://dx.doi.org/10.1074/jbc.M500292200; PMID: 15769741
   PubMed Web of Science ®Google Scholar
• Kim I, Kwak HJ, Ahn JE, So JN, Liu M, Koh KN, et al. Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. FEBS Lett 1999; 443:353 - 6; http://dx.doi.org/10.1016/S0014-5793(99)00008-3; PMID: 10025962
   PubMed Web of Science ®Google Scholar
• Maisonpierre PC, Goldfarb M, Yancopoulos GD, Gao G. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 1993; 8:1631 - 7; PMID: 7684830
   PubMed Web of Science ®Google Scholar
• Seegar TC, Eller B, Tzvetkova-Robev D, Kolev MV, Henderson SC, Nikolov DB, et al. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell 2010; 37:643 - 55; http://dx.doi.org/10.1016/j.molcel.2010.02.007; PMID: 20227369
   PubMed Web of Science ®Google Scholar
• Yuan HT, Venkatesha S, Chan B, Deutsch U, Mammoto T, Sukhatme VP, et al. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB J 2007; 21:3171 - 83; http://dx.doi.org/10.1096/fj.07-8487com; PMID: 17504972
   PubMed Web of Science ®Google Scholar
• Lin P, Polverini P, Dewhirst M, Shan S, Rao PS, Peters K. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. J Clin Invest 1997; 100:2072 - 8; http://dx.doi.org/10.1172/JCI119740; PMID: 9329972
   PubMed Web of Science ®Google Scholar
• Bäumer S, Keller L, Holtmann A, Funke R, August B, Gamp A, et al. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 2006; 107:4754 - 62; http://dx.doi.org/10.1182/blood-2006-01-0141; PMID: 16514057
   PubMed Web of Science ®Google Scholar
• Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, Kiefer F, et al. VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol 2009; 185:657 - 71; http://dx.doi.org/10.1083/jcb.200811159; PMID: 19451274
   PubMed Web of Science ®Google Scholar
• Cascone I, Napione L, Maniero F, Serini G, Bussolino F. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol 2005; 170:993 - 1004; http://dx.doi.org/10.1083/jcb.200507082; PMID: 16157706
   PubMed Web of Science ®Google Scholar
• Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, et al. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest 2012; 122:1991 - 2005; http://dx.doi.org/10.1172/JCI58832; PMID: 22585576
   PubMed Web of Science ®Google Scholar
• Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 1997; 81:567 - 74; http://dx.doi.org/10.1161/01.RES.81.4.567; PMID: 9314838
   PubMed Web of Science ®Google Scholar
• Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6:460 - 3; http://dx.doi.org/10.1038/74725; PMID: 10742156
   PubMed Web of Science ®Google Scholar
• Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286:2511 - 4; http://dx.doi.org/10.1126/science.286.5449.2511; PMID: 10617467
   PubMed Web of Science ®Google Scholar
• Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005; 111:97 - 105; http://dx.doi.org/10.1161/01.CIR.0000151287.08202.8E; PMID: 15611372
   PubMed Web of Science ®Google Scholar
• Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, et al. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem 2007; 282:23910 - 8; http://dx.doi.org/10.1074/jbc.M702169200; PMID: 17562701
   PubMed Web of Science ®Google Scholar
• Baffert F, Le T, Thurston G, McDonald DM. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol 2006; 290:H107 - 18; http://dx.doi.org/10.1152/ajpheart.00542.2005; PMID: 16126815
   PubMedGoogle Scholar
• Tadros A, Hughes DP, Dunmore BJ, Brindle NP. ABIN-2 protects endothelial cells from death and has a role in the antiapoptotic effect of angiopoietin-1. Blood 2003; 102:4407 - 9; http://dx.doi.org/10.1182/blood-2003-05-1602; PMID: 12933576
   PubMed Web of Science ®Google Scholar
• Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 2008; 10:527 - 37; http://dx.doi.org/10.1038/ncb1715; PMID: 18425119
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008; 10:513 - 26; http://dx.doi.org/10.1038/ncb1714; PMID: 18425120
   PubMed Web of Science ®Google Scholar
• Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10:165 - 77; http://dx.doi.org/10.1038/nrm2639; PMID: 19234476
   PubMed Web of Science ®Google Scholar
• Zhang J, Fukuhara S, Sako K, Takenouchi T, Kitani H, Kume T, et al. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. J Biol Chem 2011; 286:8055 - 66; http://dx.doi.org/10.1074/jbc.M110.192641; PMID: 21212269
   PubMed Web of Science ®Google Scholar
• Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46; http://dx.doi.org/10.1371/journal.pmed.0030046; PMID: 16417407
   PubMedGoogle Scholar
• Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12:235 - 9; http://dx.doi.org/10.1038/nm1351; PMID: 16462802
   PubMed Web of Science ®Google Scholar
• Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006; 12:1286 - 93; http://dx.doi.org/10.1038/nm1494; PMID: 17086189
   PubMed Web of Science ®Google Scholar
• Kurniati NF, van Meurs M, Vom Hagen F, Jongman RM, Moser J, Zwiers PJ, et al. Pleiotropic effects of angiopoietin-2 deficiency do not protect mice against endotoxin-induced acute kidney injury. Nephrol Dial Transplant 2013; 28:567 - 75; http://dx.doi.org/10.1093/ndt/gfs336; PMID: 22872727
   PubMed Web of Science ®Google Scholar
• Tzepi IM, Giamarellos-Bourboulis EJ, Carrer DP, Tsaganos T, Claus RA, Vaki I, et al. Angiopoietin-2 enhances survival in experimental sepsis induced by multidrug-resistant Pseudomonas aeruginosa. J Pharmacol Exp Ther 2012; 343:278 - 87; http://dx.doi.org/10.1124/jpet.112.195180; PMID: 22859861
   PubMed Web of Science ®Google Scholar
• Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J, et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci U S A 2006; 103:15491 - 6; http://dx.doi.org/10.1073/pnas.0607538103; PMID: 17030814
   PubMed Web of Science ®Google Scholar
• Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 2009; 29:2011 - 22; http://dx.doi.org/10.1128/MCB.01472-08; PMID: 19223473
   PubMed Web of Science ®Google Scholar
• David S, Kümpers P, van Slyke P, Parikh SM. Mending leaky blood vessels: the angiopoietin-Tie2 pathway in sepsis. J Pharmacol Exp Ther 2013; 345:2 - 6; http://dx.doi.org/10.1124/jpet.112.201061; PMID: 23378191
   PubMed Web of Science ®Google Scholar
• McCarter SD, Mei SH, Lai PF, Zhang QW, Parker CH, Suen RS, et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 2007; 175:1014 - 26; http://dx.doi.org/10.1164/rccm.200609-1370OC; PMID: 17322110
   PubMed Web of Science ®Google Scholar
• David S, Ghosh CC, Kümpers P, Shushakova N, Van Slyke P, Khankin EV, et al. Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality. Am J Physiol Lung Cell Mol Physiol 2011; 300:L851 - 62; http://dx.doi.org/10.1152/ajplung.00459.2010; PMID: 21421750
   PubMedGoogle Scholar
• Van Slyke P, Alami J, Martin D, Kuliszewski M, Leong-Poi H, Sefton MV, et al. Acceleration of diabetic wound healing by an angiopoietin peptide mimetic. Tissue Eng Part A 2009; 15:1269 - 80; http://dx.doi.org/10.1089/ten.tea.2007.0400; PMID: 18939935
   PubMed Web of Science ®Google Scholar
• Kumpers P, Gueler F, David S, Slyke PV, Dumont DJ, Park JK, et al. The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care 2011; 15:R261; http://dx.doi.org/10.1186/cc10523; PMID: 22040774
   PubMed Web of Science ®Google Scholar
• Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, van der Poll T. Preclinical models of shock and sepsis: what can they tell us?. Shock 2005; 24:Suppl 1 1 - 6; http://dx.doi.org/10.1097/01.shk.0000191383.34066.4b; PMID: 16374365
   PubMedGoogle Scholar
• Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al, Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013; 110:3507 - 12; http://dx.doi.org/10.1073/pnas.1222878110; PMID: 23401516
   PubMed Web of Science ®Google Scholar
• Yamakawa D, Kidoya H, Sakimoto S, Jia W, Naito H, Takakura N. Ligand-independent Tie2 dimers mediate kinase activity stimulated by high dose Angiopoietin-1. J Biol Chem 2013; 288:12469 - 77; http://dx.doi.org/10.1074/jbc.M112.433979; PMID: 23504320
   PubMed Web of Science ®Google Scholar
• Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011; 121:2278 - 89; http://dx.doi.org/10.1172/JCI46322; PMID: 21606590
   PubMed Web of Science ®Google Scholar
• Giuliano JS Jr., Lahni PM, Harmon K, Wong HR, Doughty LA, Carcillo JA, et al. Admission angiopoietin levels in children with septic shock. Shock 2007; 28:650 - 4; PMID: 18092380
   PubMed Web of Science ®Google Scholar
• Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011; 39:702 - 10; http://dx.doi.org/10.1097/CCM.0b013e318206d285; PMID: 21242795
   PubMed Web of Science ®Google Scholar
• David S, van Meurs M, Kümpers P. Does low angiopoietin-1 predict adverse outcome in sepsis?. Crit Care 2010; 14:180; http://dx.doi.org/10.1186/cc9090; PMID: 20727223
   PubMed Web of Science ®Google Scholar
• van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008; 63:903 - 9; http://dx.doi.org/10.1136/thx.2007.087387; PMID: 18559364
   PubMed Web of Science ®Google Scholar
• Gallagher DC, Parikh SM, Balonov K, Miller A, Gautam S, Talmor D, et al. Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 2008; 29:656 - 61; PMID: 18091573
   PubMed Web of Science ®Google Scholar
• Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA, NHLBI ARDS Network. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med 2012; 40:1731 - 7; http://dx.doi.org/10.1097/CCM.0b013e3182451c87; PMID: 22610178
   PubMed Web of Science ®Google Scholar
• Diamond JM, Porteous MK, Cantu E, Meyer NJ, Shah RJ, Lederer DJ, et al, Lung Transplant Outcomes Group. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One 2012; 7:e51932; http://dx.doi.org/10.1371/journal.pone.0051932; PMID: 23284823
   PubMed Web of Science ®Google Scholar
• Gallagher DC, Bhatt RS, Parikh SM, Patel P, Seery V, McDermott DF, et al. Angiopoietin 2 is a potential mediator of high-dose interleukin 2-induced vascular leak. Clin Cancer Res 2007; 13:2115 - 20; http://dx.doi.org/10.1158/1078-0432.CCR-06-2509; PMID: 17404094
   PubMed Web of Science ®Google Scholar
• van der Heijden M, Pickkers P, van Nieuw Amerongen GP, van Hinsbergh VW, Bouw MP, van der Hoeven JG, et al. Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009; 35:1567 - 74; http://dx.doi.org/10.1007/s00134-009-1560-y; PMID: 19551369
   PubMed Web of Science ®Google Scholar
• Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, Hawkes M, et al. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One 2009; 4:e4912; http://dx.doi.org/10.1371/journal.pone.0004912; PMID: 19300530
   PubMed Web of Science ®Google Scholar
• Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A 2008; 105:17097 - 102; http://dx.doi.org/10.1073/pnas.0805782105; PMID: 18957536
   PubMed Web of Science ®Google Scholar
• Ghosh CC, Mukherjee A, David S, Knaus UG, Stearns-Kurosawa DJ, Kurosawa S, et al. Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax. Proc Natl Acad Sci U S A 2012; 109:10024 - 9; http://dx.doi.org/10.1073/pnas.1120755109; PMID: 22665799
   PubMed Web of Science ®Google Scholar
• Whitcomb DC, Muddana V, Langmead CJ, Houghton FD Jr., Guenther A, Eagon PK, et al. Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany. Am J Gastroenterol 2010; 105:2287 - 92; http://dx.doi.org/10.1038/ajg.2010.183; PMID: 20461065
   PubMed Web of Science ®Google Scholar
• Ganter MT, Cohen MJ, Brohi K, Chesebro BB, Staudenmayer KL, Rahn P, et al. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?. Ann Surg 2008; 247:320 - 6; http://dx.doi.org/10.1097/SLA.0b013e318162d616; PMID: 18216540
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Kanellakopoulou K, Pelekanou A, Tsaganos T, Kotzampassi K. Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity. Cytokine 2008; 44:310 - 3; http://dx.doi.org/10.1016/j.cyto.2008.09.003; PMID: 18952457
   PubMed Web of Science ®Google Scholar
• Page AV, Kotb M, McGeer A, Low DE, Kain KC, Liles WC. Systemic dysregulation of angiopoietin-1/2 in streptococcal toxic shock syndrome. Clin Infect Dis 2011; 52:e157 - 61; http://dx.doi.org/10.1093/cid/cir125; PMID: 21460306
   PubMed Web of Science ®Google Scholar
• Hill AB. The environment and disease: association or causation?. Proc R Soc Med 1965; 58:295 - 300; PMID: 14283879
   PubMed Web of Science ®Google Scholar
• David S, Mukherjee A, Ghosh CC, Yano M, Khankin EV, Wenger JB, et al. Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis*. Crit Care Med 2012; 40:3034 - 41; http://dx.doi.org/10.1097/CCM.0b013e31825fdc31; PMID: 22890252
   PubMed Web of Science ®Google Scholar
• Kümpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, et al. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008; 12:R147; http://dx.doi.org/10.1186/cc7130; PMID: 19025590
   PubMedGoogle Scholar
• Meyer NJ, Li M, Feng R, Bradfield J, Gallop R, Bellamy S, et al. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 2011; 183:1344 - 53; http://dx.doi.org/10.1164/rccm.201005-0701OC; PMID: 21257790
   PubMed Web of Science ®Google Scholar
• Su L, Zhai R, Sheu CC, Gallagher DC, Gong MN, Tejera P, et al. Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med 2009; 35:1024 - 30; http://dx.doi.org/10.1007/s00134-009-1413-8; PMID: 19271210
   PubMed Web of Science ®Google Scholar
• Tabruyn SP, Colton K, Morisada T, Fuxe J, Wiegand SJ, Thurston G, et al. Angiopoietin-2-driven vascular remodeling in airway inflammation. Am J Pathol 2010; 177:3233 - 43; http://dx.doi.org/10.2353/ajpath.2010.100059; PMID: 20952594
   PubMed Web of Science ®Google Scholar
• Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, Lee SH, et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 2004; 101:5547 - 52; http://dx.doi.org/10.1073/pnas.0307574101; PMID: 15060279
   PubMed Web of Science ®Google Scholar
• Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007; 35:199 - 206; http://dx.doi.org/10.1097/01.CCM.0000251640.77679.D7; PMID: 17110873
   PubMed Web of Science ®Google Scholar
• Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD. Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009; 31:348 - 53; http://dx.doi.org/10.1097/SHK.0b013e318188bd06; PMID: 18791490
   PubMed Web of Science ®Google Scholar
• Kümpers P, van Meurs M, David S, Molema G, Bijzet J, Lukasz A, et al. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care 2009; 13:R64; http://dx.doi.org/10.1186/cc7866; PMID: 19416526
   PubMedGoogle Scholar
• Ebihara I, Hirayama K, Nagai K, Kakita T, Miyamoto Y, Nagai M, et al. Angiopoietin balance in septic shock patients treated by direct hemoperfusion with polymyxin b-immobilized fiber. Ther Apher Dial 2009; 13:520 - 7; http://dx.doi.org/10.1111/j.1744-9987.2009.00777.x; PMID: 19954476
   PubMed Web of Science ®Google Scholar
• Kümpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, et al. Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 2010; 36:462 - 70; http://dx.doi.org/10.1007/s00134-009-1726-7; PMID: 19956923
   PubMed Web of Science ®Google Scholar
• Davis JS, Yeo TW, Piera KA, Woodberry T, Celermajer DS, Stephens DP, et al. Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 2010; 14:R89; http://dx.doi.org/10.1186/cc9020; PMID: 20482750
   PubMed Web of Science ®Google Scholar
• Mankhambo LA, Banda DL, Jeffers G, White SA, Balmer P, Nkhoma S, et al, IPD Study Group. The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit Care 2010; 14:R91; http://dx.doi.org/10.1186/cc9025; PMID: 20492647
   PubMed Web of Science ®Google Scholar
• Alves BE, Montalvao SA, Aranha FJ, Siegl TF, Souza CA, Lorand-Metze I, et al. Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia. BMC Infect Dis 2010; 10:143; http://dx.doi.org/10.1186/1471-2334-10-143; PMID: 20509945
   PubMed Web of Science ®Google Scholar